Systane Balance
Drug
Alcon Research Ltd
Total Payments
$309,403
Transactions
172
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2017 | $309,403 | 172 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $309,403 | 172 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Clinical evaluation following use of Systane Balance in Patients with Lipid deficient dry eye (Systane Balance vs. Optive Advance Study) | Alcon Research Ltd | $309,403 | 0 |
Top Doctors Receiving Payments for Systane Balance
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Kansas City, MO | $309,403 | 172 |
Ad
Manufacturing Companies
- Alcon Research Ltd $309,403
Product Information
- Type Drug
- Total Payments $309,403
- Total Doctors 0
- Transactions 172
About Systane Balance
Systane Balance is a drug associated with $309,403 in payments to 0 healthcare providers, recorded across 172 transactions in the CMS Open Payments database. The primary manufacturer is Alcon Research Ltd.
Payment data is available from 2017 to 2017. In 2017, $309,403 was paid across 172 transactions to 0 doctors.
The most common payment nature for Systane Balance is "Unspecified" ($309,403, 100.0% of total).
Systane Balance is associated with 1 research study, including "Clinical evaluation following use of Systane Balance in Patients with Lipid deficient dry eye (Systane Balance vs. Optive Advance Study)" ($309,403).